Wells Fargo downgraded Affimed (AFMD) to Equal Weight from Overweight with a price target of 10c, down from $11, following the announcement that the company is opening insolvency proceedings given that the company’s liquidity condition raises substantial doubt about its ability to continue as a going concern. Though there is value in acimtamig, the small market opportunity likely has limited the company’s ability to access capital, the analyst tells investors.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AFMD: